These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Rapid differentiation of Streptococcus milleri from other beta-haemolytic group A, C, and G streptococci by simple screening tests.
    Author: O'Neill WA, Cooke RP.
    Journal: Br J Biomed Sci; 1994 Mar; 51(1):1-4. PubMed ID: 7841829.
    Abstract:
    Eighty five beta-haemolytic Lancefield group A(23), C(22), and G(40) streptococci were tested for sulphonamide sensitivity, ability to degrade beta-D glucuronide (groups C and G) and bacitracin sensitivity (group A). Identification of isolates was initially confirmed by the API 20 STREP system. Zones of beta-haemolysis were too variable for correct Streptococcus milleri identification in 10% of cases. However, only group C and G S. milleri were both sulphonamide-resistant and beta-D glucuronide-negative. Two group A S. milleri strains could have been mis-identified as Streptococcus pyogenes if combined sulphonamide and bacitracin resistance had not been noted. In a busy diagnostic laboratory, screening of beta-haemolytic group A, C, and G streptococci for sulphonamide sensitivity is recommended. Sulphonamide-resistant group A S. pyogenes can be distinguished from S. milleri by bacitracin sensitivity. S. milleri can be rapidly and cheaply differentiated from other sulphonamide-resistant group C and G streptococci by a simple 4 h commercial beta-D glucuronide assay.
    [Abstract] [Full Text] [Related] [New Search]